All practice questions

8270 questions

All types8,270 Multiple choice4,249 Multiple select325 Numeric160 Matching1,849 Ordering1,687

A 54-year-old woman is evaluated in the intensive care unit for worsening respiratory distress. She was admitted 48 hours ago for a severe right lower lobe community-acquired pneumonia and was started on intravenous ceftriaxone and azithromycin. Blood and sputum cultures drawn on admission are now growing *Streptococcus pneumoniae* susceptible to penicillin.

Current vital signs are:
Temperature: 38.9°C (102.0°F)
Pulse: 124/min
Blood pressure: 82/50 mmHg
Respirations: 32/min
SpO2: 87% on a high-flow nasal cannula (FiO2 60%)

Over the past 4 hours, she has received 3 L of intravenous normal saline without improvement in her blood pressure. Physical examination reveals cool, mottled extremities. Jugular venous pressure is 5 cm H2O. Pulmonary auscultation reveals diffuse bilateral crackles, a change from the isolated right-sided crackles noted on admission. A bedside chest radiograph demonstrates new, diffuse bilateral alveolar opacities in addition to the right lower lobe consolidation.

Laboratory results:
Leukocytes: 18,500/mm³
Serum sodium: 138 mEq/L
Serum potassium: 4.8 mEq/L
Serum chloride: 101 mEq/L
Serum bicarbonate: 13 mEq/L
Blood urea nitrogen: 34 mg/dL
Serum creatinine: 2.2 mg/dL
Serum lactate: 6.5 mmol/L

Arterial blood gas (on HFNC 60%):
pH: 7.20
PaCO2: 35 mmHg
PaO2: 55 mmHg

Which of the following statements regarding this patient's condition and management are correct? (Select all that apply)

Select all that apply

The patient has a mixed metabolic acidosis and concurrent respiratory acidosis

Initiation of a continuous intravenous norepinephrine infusion is indicated

Intravenous furosemide should be administered to treat the new bilateral alveolar opacities

Antibiotic therapy should be broadened to include intravenous vancomycin

The arterial blood gas values indicate appropriate physiological respiratory compensation

Show answer & explanation

Answer: The patient has a mixed metabolic acidosis and concurrent respiratory acidosis; Initiation of a continuous intravenous norepinephrine infusion is indicated

Answer

The patient has a mixed metabolic acidosis with concurrent respiratory acidosis, and requires initiation of a continuous intravenous norepinephrine infusion.

The patient is experiencing fluid-refractory septic shock complicated by Acute Respiratory Distress Syndrome (ARDS) and impending respiratory failure. Despite 3 L of crystalloids, she remains hypotensive, mandating the initiation of a vasopressor (norepinephrine is first-line). Additionally, she has a severe high anion gap metabolic acidosis (lactate 6.5 mmol/L, HCO3 13 mEq/L). Winter's formula calculation (

PaCO_2 = (1.5 \times 13) + 8 \pm 2

) predicts an expected PaCO2 of 25.5 to 29.5 mmHg. Her actual PaCO2 of 35 mmHg is higher than expected, indicating inadequate respiratory compensation and a concurrent respiratory acidosis due to muscle fatigue and ARDS.

Step-by-Step Solution

Assess the patient's hemodynamic status and response to initial resuscitation.

The patient remains severely hypotensive (BP 82/50 mmHg) despite receiving 3 L of intravenous fluids, indicating fluid-refractory septic shock.

Identifying fluid-refractory shock determines the need for immediate vasopressor support, with norepinephrine being the first-line agent.

Analyze the arterial blood gas to determine the primary acid-base disorder.

The pH is 7.20 (acidemia) and HCO3 is 13 mEq/L, confirming a primary metabolic acidosis (driven by elevated lactate).

Establishing the primary disorder is required before calculating the expected physiological compensatory response.

Calculate the expected respiratory compensation using Winter's formula.

PaCO_2 = (1.5 \times 13) + 8 \pm 2 = 27.5 \pm 2\text{ mmHg}

. The measured PaCO2 (35 mmHg) is higher than expected.

Comparing measured to expected PaCO2 reveals a concurrent respiratory acidosis, indicating the patient's work of breathing is failing and complete respiratory collapse is imminent.

Evaluate the clinical and radiographic pulmonary findings in the context of sepsis.

New diffuse bilateral alveolar opacities and severe hypoxemia in a septic patient signify Acute Respiratory Distress Syndrome (ARDS), a form of noncardiogenic pulmonary edema.

Distinguishing ARDS from cardiogenic edema ensures inappropriate treatments like diuretics are avoided in a hypoperfused, hypovolemic state.

Key Concept

In patients with severe metabolic acidosis, failure to achieve the target PaCO2 calculated by Winter's formula indicates a concurrent respiratory acidosis and impending respiratory failure. Fluid-refractory septic shock requires prompt initiation of norepinephrine.

Question 7222Question →

During a routine outpatient follow-up, a 69-year-old retired carpenter complains of gradually increasing swelling in both ankles over the past month. He has a 45-pack-year smoking history and severe chronic obstructive pulmonary disease. The patient states his chronic daily cough and baseline exertional shortness of breath have not worsened. He denies waking up gasping for air at night and sleeps comfortably on a single pillow. He is afebrile. Vital signs show a blood pressure of 118/76 mm Hg, a pulse of 84/min, and a respiratory rate of 18/min. Pulse oximetry reveals an oxygen saturation of 87% on room air. Physical examination demonstrates an elevated jugular venous pressure, a prominent right ventricular heave, and 2+ bilateral pitting edema up to the shins. Auscultation of the lungs reveals distant breath sounds with prolonged expiration but no crackles. A basic metabolic panel reveals a serum bicarbonate of 32 mEq/L. Which of the following management steps is most likely to improve this patient's long-term survival?

Initiation of daily oral torsemide

Prescription of a broad-spectrum fluoroquinolone

Provision of continuous supplemental oxygen

Administration of intravenous sodium bicarbonate

Initiation of daily carvedilol therapy

Show answer & explanation

Answer: Provision of continuous supplemental oxygen

Answer

Provision of continuous supplemental oxygen

The correct answer provides continuous supplemental oxygen. This patient presents with classic signs of cor pulmonale (right-sided heart failure secondary to pulmonary disease), evidenced by his elevated jugular venous pressure, right ventricular heave, and peripheral edema in the setting of severe COPD. The underlying mechanism is chronic hypoxic pulmonary vasoconstriction leading to pulmonary hypertension and right ventricular hypertrophy. Long-term oxygen therapy (LTOT) is the most critical intervention because it reverses this hypoxic vasoconstriction, lowers pulmonary artery pressures, and is one of the only treatments definitively proven to improve survival in COPD patients. Criteria for LTOT include a resting

PaO_2 \leq 55

mm Hg or an

SaO_2 \leq 88\%

on room air. Since this patient's

SaO_2

87\%

, he meets the criteria.

Step-by-Step Solution

Analyze the clinical presentation.

The patient has signs of isolated right heart failure (JVD, right ventricular heave, pedal edema) without left heart failure signs (no orthopnea, no pulmonary crackles).

To identify the underlying pathophysiology as cor pulmonale secondary to severe COPD.

Evaluate the objective data.

The patient has severe resting hypoxemia (SpO2 is 87%).

To determine whether the patient meets the clinical criteria for specific evidence-based interventions.

Select the intervention proven to improve mortality.

Long-term supplemental oxygen therapy (LTOT).

LTOT is one of the few therapies demonstrated to improve long-term survival in patients with severe COPD and resting hypoxemia by reducing pulmonary vascular resistance.

Key Concept

Continuous long-term oxygen therapy (LTOT) improves survival in patients with COPD who have severe resting hypoxemia (

PaO_2 \leq 55

mm Hg or

SaO_2 \leq 88\%

) or moderate hypoxemia with evidence of cor pulmonale.

Estimated Time:1m 0s

Question 7223Question →

A 42-year-old woman presents to the clinic with progressively worsening exertional dyspnea and fatigue over the past 6 months. She has no significant past medical history and takes no medications. Physical examination reveals a prominent jugular venous a-wave, a loud pulmonic component of the second heart sound (P2), a right ventricular heave, and trace bilateral pedal edema. Her lungs are clear to auscultation. Pulmonary function testing demonstrates normal spirometry with an isolated reduction in the diffusing capacity of the lungs for carbon monoxide (DLCO). Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for evaluating and managing this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with echocardiography, followed by a V/Q scan, right heart catheterization, vasoreactivity testing, and finally initiation of a calcium channel blocker.

The diagnostic algorithm for pulmonary hypertension (PH) begins with suspected clinical signs such as a loud P2 and right ventricular heave, along with isolated reduced DLCO. Transthoracic echocardiography is the initial screening test to estimate pulmonary artery pressures and evaluate for Group 2 (left heart) disease. Once Group 2 and Group 3 (lung parenchymal) diseases are excluded, a V/Q scan is required to screen for Group 4 (chronic thromboembolic PH), which has a distinct surgical cure and requires specialized diagnostic imaging during subsequent catheterization. Right heart catheterization is then performed to definitively confirm pre-capillary PAH (Group 1). During catheterization, acute vasoreactivity testing (using nitric oxide, epoprostenol, or adenosine) identifies a small subset of vasoreactive patients. Only these specific patients should be treated with high-dose calcium channel blockers.

Step-by-Step Solution

Perform transthoracic echocardiography

Estimates pulmonary pressures and rules out left heart disease.

Initial screening test of choice for suspected pulmonary hypertension.

Perform a ventilation-perfusion (V/Q) scan

Screens for chronic thromboembolic pulmonary hypertension (CTEPH).

Guidelines mandate V/Q scanning to rule out Group 4 pulmonary hypertension before invasive testing.

Perform right heart catheterization

Confirms the diagnosis of pulmonary arterial hypertension (PAH).

Gold standard required to directly measure hemodynamics and definitively diagnose pre-capillary pulmonary hypertension.

Perform acute vasoreactivity testing with inhaled nitric oxide

Assesses the pulmonary vasculature's ability to dilate.

Performed during the right heart catheterization to identify patients with idiopathic PAH who will respond to calcium channel blockers.

Initiate therapy with a high-dose oral calcium channel blocker

Reduces pulmonary pressures and improves symptoms.

The targeted first-line medical therapy exclusively for patients who demonstrate a positive acute vasoreactivity test.

Key Concept

The diagnostic and therapeutic algorithm for pulmonary arterial hypertension.

Estimated Time:2m 0s

Question 7224Question →

A $74$ -year-old woman is brought to the emergency department via ambulance with acute, severe respiratory distress that awoke her from sleep $30$ minutes ago. She is profoundly diaphoretic, anxious, and sitting bolt upright on the stretcher. Her blood pressure is $240/130$ mm Hg, heart rate is $128$ /min, and respiratory rate is $38$ /min. Oxygen saturation is $82\%$ on room air. Physical examination reveals a hyperdynamic precordium and diffuse, coarse crackles auscultated throughout all lung fields bilaterally. There is no significant lower extremity edema. Arrange the following therapeutic interventions in the most appropriate chronological sequence for the optimal acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of interventions begins with airway support using BiPAP, followed by rapid afterload reduction with high-dose intravenous nitroglycerin, subsequent volume management with a loop diuretic, weaning of intravenous therapies, and finally transitioning to chronic oral heart failure medications.

This patient presents with sympathetic crashing acute pulmonary edema (SCAPE), a severe form of acute decompensated heart failure triggered by a massive sympathetic surge. This leads to extreme vasoconstriction (afterload), forcing fluid out of the systemic circulation into the pulmonary vasculature. The correct management sequence addresses the most immediate threats first. Noninvasive positive pressure ventilation (BiPAP) is paramount to prevent respiratory failure and provides immediate hemodynamic benefits by reducing preload and afterload. This must be rapidly followed by a high-dose intravenous vasodilator (like nitroglycerin) to break the cycle of sympathetic vasoconstriction. Only after these immediate stabilizing measures should loop diuretics be administered, as SCAPE is primarily a disease of fluid redistribution rather than profound absolute volume overload, and diuretics have a delayed onset of action. Finally, acute therapies are weaned as the patient is transitioned to chronic oral heart failure medications.

Step-by-Step Solution

Identify the primary pathophysiological mechanism.

The patient is experiencing sympathetic crashing acute pulmonary edema (SCAPE), characterized by extreme hypertension driving acute fluid redistribution into the lungs.

Recognizing SCAPE is crucial because the treatment prioritizes rapid afterload reduction over slow diuresis.

Prioritize immediate life-saving interventions (ABCs).

BiPAP is selected as the first intervention.

Severe hypoxia and respiratory muscle fatigue are the most immediate threats to life. BiPAP rapidly improves oxygenation and provides beneficial hemodynamic effects.

Select the primary pharmacological intervention to reverse the underlying cause.

High-dose intravenous nitroglycerin is administered next.

The core problem is extreme afterload and venoconstriction. Nitroglycerin rapidly dilates the vasculature, relieving pulmonary congestion within minutes.

Address secondary volume status issues.

An intravenous loop diuretic is given after the vasodilator.

Patients with SCAPE are often euvolemic or only mildly hypervolemic. Diuretics take longer to act and are less critical than immediate afterload reduction in this specific phenotype.

Plan post-resuscitation care and transition to chronic management.

Intravenous medications are weaned, and oral therapies are initiated.

Long-term stabilization requires weaning off acute therapies and establishing a chronic regimen to prevent future decompensation.

Key Concept

In sympathetic crashing acute pulmonary edema (SCAPE), rapid afterload and preload reduction with noninvasive ventilation and high-dose vasodilators takes precedence over loop diuretics, as the primary mechanism is acute fluid redistribution rather than absolute volume overload.

Estimated Time:1m 30s

Question 7225Question →

A 55-year-old man is evaluated in the intensive care unit on his fourth day of mechanical ventilation for acute respiratory distress syndrome secondary to severe pneumonia. Over the past 48 hours, his clinical status has markedly improved. His fraction of inspired oxygen (FiO2) requirement has decreased to 35%, his positive end-expiratory pressure (PEEP) is at a minimal setting, and he no longer requires vasopressor support. The critical care team decides to initiate the protocol to liberate him from the ventilator. Arrange the following steps in the standard sequential order for evaluating and performing ventilator liberation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for ventilator liberation is: screening for clinical readiness criteria, followed by a spontaneous awakening trial, then a spontaneous breathing trial, and finally extubation.

The standard evidence-based protocol for liberating a patient from mechanical ventilation involves sequential escalation of independence. First, the clinician must confirm the patient meets objective readiness criteria (e.g., FiO2 less than or equal to 40%, PEEP less than or equal to 5-8 cm H2O, hemodynamic stability). Second, a spontaneous awakening trial (SAT) is performed by turning off continuous sedatives to ensure the patient is neurologically intact and has an adequate respiratory drive. Third, if the SAT is passed, a spontaneous breathing trial (SBT) is performed using minimal ventilator settings (like CPAP or T-piece) for 30-120 minutes. Finally, if the patient tolerates the SBT without distress, extubation is performed.

Step-by-Step Solution

Determine clinical readiness

Confirming hemodynamic stability and adequate oxygenation on minimal settings.

Ensures the patient is physiologically capable of tolerating the stress of weaning before interventions are started.

Stop continuous sedation

Execution of a spontaneous awakening trial (SAT).

The patient must be awake to follow commands, protect their airway, and drive their own respiratory effort.

Test independent breathing

Execution of a spontaneous breathing trial (SBT).

Proves the patient can maintain the work of breathing and normal gas exchange without full mechanical support.

Remove the artificial airway

Extubation of the patient.

The patient has proven capable of independent respiration and airway protection.

Key Concept

Liberation from mechanical ventilation follows a standardized, stepwise approach to maximize safety and success: assessing objective readiness criteria, performing a spontaneous awakening trial (SAT), conducting a spontaneous breathing trial (SBT), and proceeding to extubation.

Question 7226Question →

An emergency department physician evaluates a 67-year-old man due to four days of escalating dyspnea and nocturnal coughing. The patient reports having to sleep upright in a recliner to avoid respiratory distress. His medical background includes type 2 diabetes, essential hypertension, and osteoarthritis. He recently began taking over-the-counter ibuprofen around the clock for severe knee pain. He smoked one pack of cigarettes daily for 35 years but ceased a decade ago. Temperature is 37.0°C (98.6°F), blood pressure is 158/92 mm Hg, pulse is 112/min, and respirations are 22/min. Pulse oximetry is 92% on room air. Physical examination reveals an anxious patient utilizing accessory respiratory muscles. Jugular venous pressure is elevated at 11 cm H2O. Chest auscultation demonstrates bibasilar dullness to percussion and widespread expiratory wheezes. Cardiac evaluation shows a regular rhythm with a normal S1 and S2, accompanied by a low-frequency sound occurring shortly after S2. Moderate pitting edema is present up to the mid-shins bilaterally. Which of the following is the most appropriate initial pharmacotherapy for this patient?

Intravenous bumetanide

Nebulized albuterol

Intravenous methylprednisolone

Oral levofloxacin

Subcutaneous enoxaparin

Show answer & explanation

Answer: Intravenous bumetanide

Answer

Intravenous bumetanide

The correct choice is intravenous bumetanide because this patient is presenting with classic signs of acute decompensated heart failure (ADHF). The recent daily use of ibuprofen (an NSAID) likely precipitated fluid retention, leading to pulmonary and systemic venous congestion. Key findings driving this diagnosis include orthopnea, elevated jugular venous pressure, an S3 gallop, and peripheral edema. The wheezing noted on examination represents 'cardiac asthma' caused by peribronchial edema, rather than primary bronchospasm. Intravenous loop diuretics (such as bumetanide or furosemide) are the most appropriate initial therapy to rapidly decrease intravascular volume, lower ventricular filling pressures, and relieve pulmonary edema.

Step-by-Step Solution

Analyze the patient's presenting symptoms and history.

The patient has subacute dyspnea, orthopnea (sleeping in a recliner), a history of hypertension, and recent initiation of daily NSAIDs (ibuprofen).

Identifying the timeline and triggers helps narrow the differential diagnosis. NSAIDs can cause sodium and fluid retention, precipitating heart failure.

Interpret the physical examination findings.

Findings include elevated JVP, an S3 gallop (low-frequency sound after S2), bibasilar dullness, wheezing, and bilateral pitting edema.

These findings definitively point to left and right ventricular fluid overload. The S3 gallop is highly specific for elevated left ventricular filling pressures.

Differentiate between cardiac and pulmonary etiologies of wheezing.

Although the patient has a smoking history and wheezing, the concurrent S3 gallop, orthopnea, and volume overload confirm 'cardiac asthma' due to acute decompensated heart failure, rather than a COPD exacerbation.

Peribronchial edema in heart failure can cause airway narrowing and wheezing that mimics primary pulmonary disease.

Determine the most appropriate initial therapy.

The patient requires immediate preload reduction and diuresis with an intravenous loop diuretic.

Loop diuretics (like bumetanide or furosemide) rapidly improve pulmonary congestion and symptoms of acute decompensated heart failure.

Key Concept

Differentiating acute decompensated heart failure (which can present with wheezing known as 'cardiac asthma') from COPD exacerbation, and treating appropriately with intravenous loop diuretics.

Question 7227Question →

During morning rounds in the medical intensive care unit, a physician evaluates a 69-year-old male who was intubated two days prior for hypercapnic respiratory failure. The patient has a medical history significant for severe emphysema and hypertension. He initially presented to the emergency department with a severe exacerbation characterized by a productive cough and severe dyspnea, leading to emergent intubation. He is currently mechanically ventilated in the volume assist-control mode.

Today, his temperature is $38.9^\circ\text{C}$ ( $102.0^\circ\text{F}$ ), blood pressure is $94/62\text{ mm Hg}$ , heart rate is $116/\text{min}$ , and oxygen saturation is $93\%$ on an $FiO_2$ of $0.50$ and a positive end-expiratory pressure (PEEP) of $8\text{ cm H}_2\text{O}$ . The set respiratory rate is $14/\text{min}$ .

Physical examination reveals diminished breath sounds bilaterally with a notably prolonged expiratory phase. A central venous catheter and a pulmonary artery catheter are in place. Hemodynamic monitoring shows a central venous pressure (CVP) of $15\text{ mm Hg}$ and a pulmonary capillary wedge pressure (PCWP) of $10\text{ mm Hg}$ .

Laboratory results are as follows:
Leukocyte count: $19,200/\text{mm}^3$
Serum sodium: $141\text{ mEq/L}$
Serum chloride: $103\text{ mEq/L}$
Serum bicarbonate: $16\text{ mEq/L}$
Serum creatinine: $1.9\text{ mg/dL}$ (baseline $1.1\text{ mg/dL}$ )

Arterial blood gas analysis (on current ventilator settings):
pH: $7.24$
$pCO_2$ : $38\text{ mm Hg}$
$pO_2$ : $65\text{ mm Hg}$

A tracheal aspirate culture obtained at the time of intubation has grown heavy growth of *Staphylococcus aureus* that is susceptible to oxacillin, cefazolin, and vancomycin. The patient is currently receiving empiric intravenous meropenem and vancomycin.

Which of the following is the most appropriate next step in the management of this patient?

Discontinue meropenem and vancomycin, and initiate intravenous cefazolin

Administer intravenous bumetanide and restrict maintenance fluids

Increase the mechanical ventilator respiratory rate

Administer an intravenous bolus of sodium bicarbonate

Continue the current antimicrobial regimen to ensure broad-spectrum coverage

Show answer & explanation

Answer: Discontinue meropenem and vancomycin, and initiate intravenous cefazolin

Answer

The most appropriate step is to discontinue the broad-spectrum antibiotics (meropenem and vancomycin) and initiate targeted therapy with intravenous cefazolin.

The correct answer emphasizes antimicrobial stewardship. The patient has a confirmed pneumonia caused by Methicillin-susceptible Staphylococcus aureus (MSSA). Continuing ultra-broad-spectrum agents like meropenem and vancomycin exposes the patient to unnecessary risks (e.g., nephrotoxicity, resistance). Targeted beta-lactam therapy with cefazolin is definitively indicated and provides superior clinical outcomes for MSSA compared to vancomycin. No changes to the ventilator or fluid status are indicated because his hemodynamics reflect right-sided strain without left-sided failure, and his ventilator settings are appropriately maintaining permissive hypercapnia to avoid auto-PEEP.

Step-by-Step Solution

Analyze the patient's hemodynamic profile.

The patient has an elevated CVP (

15\text{ mm Hg}

) but a normal PCWP (

10\text{ mm Hg}

This isolates the pressure elevation to the right side of the heart, which is expected in severe COPD (cor pulmonale) combined with positive pressure ventilation. It rules out cardiogenic shock or fluid overload as the cause of his hypotension, meaning diuresis is contraindicated.

Evaluate the acid-base status by calculating the anion gap.

Anion Gap (AG) =

\text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-)

141 - (103 + 16) = 22

An elevated AG indicates a primary anion gap metabolic acidosis, likely secondary to lactic acidosis from sepsis and acute kidney injury.

Apply Winter's formula to determine if respiratory compensation is adequate.

Expected

pCO_2 = 1.5 \times [\text{HCO}_3^-] + 8 \pm 2 = (1.5 \times 16) + 8 = 32 \pm 2\text{ mm Hg}

Because the actual

pCO_2

(

38\text{ mm Hg}

) is higher than the expected range (

30-34\text{ mm Hg}

), there is a concurrent primary respiratory acidosis. The patient is unable to adequately compensate due to severe emphysema.

Determine the safest ventilator strategy given the mixed acidosis.

Maintain current settings; do not increase the respiratory rate.

Attempting to 'fix' the respiratory acidosis by increasing the respiratory rate in a patient with severe COPD reduces expiratory time. This leads to air trapping and dynamic hyperinflation (auto-PEEP), which decreases venous return and would fatally worsen his hypotension. A pH of

7.24

is well within safe limits for permissive hypercapnia.

Implement antimicrobial stewardship based on culture data.

De-escalate meropenem and vancomycin to cefazolin.

The tracheal aspirate confirms a Methicillin-susceptible Staphylococcus aureus (MSSA) pneumonia. Cefazolin is a highly effective, narrow-spectrum beta-lactam that is the standard of care for MSSA, preventing the selective pressure and toxicities associated with unnecessarily broad regimens.

Key Concept

Complex ICU management requires integrating hemodynamics to rule out cardiogenic edema, using Winter's formula to identify mixed acid-base disorders, employing permissive hypercapnia to avoid auto-PEEP in COPD, and adhering to antimicrobial stewardship by de-escalating to targeted therapy.

Estimated Time:2m 30s

Question 7228Question →

A 24-year-old woman is brought to the emergency department for severe shortness of breath that began 8 hours ago. She has a history of persistent asthma that has been poorly controlled over the past month. On arrival, she is visibly exhausted, diaphoretic, and speaking in single words.

Vital signs are:
Temperature: $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ )
Blood pressure: 138/85 mm Hg
Heart rate: 128/min
Respiratory rate: 32/min
Oxygen saturation: 91% on room air.

Physical examination reveals profound accessory muscle use, paradoxical abdominal breathing, and diffuse expiratory wheezing. She is immediately started on continuous nebulized albuterol and ipratropium, intravenous methylprednisolone, and supplemental oxygen.

Forty-five minutes later, the patient states she is feeling 'too tired to breathe.' Her heart rate is 115/min and her respiratory rate is 16/min. Lung auscultation reveals markedly diminished breath sounds bilaterally with minimal wheezing. Arterial blood gas analysis on 40% $\text{FiO}_2$ reveals:

$\text{pH}$ : 7.37
$\text{PaCO}_2$ : 44 mm Hg
$\text{PaO}_2$ : 68 mm Hg
$\text{HCO}_3^-$ : 24 mEq/L

Which of the following is the most appropriate next step in management?

Endotracheal intubation and mechanical ventilation

Initiation of noninvasive positive-pressure ventilation

Performance of bedside echocardiography

Administration of broad-spectrum intravenous antibiotics

Continuation of current medical therapy and close observation

Show answer & explanation

Answer: Endotracheal intubation and mechanical ventilation

Answer

The most appropriate next step in management is endotracheal intubation and mechanical ventilation.

The correct answer is endotracheal intubation and mechanical ventilation. This patient is experiencing a severe asthma exacerbation complicated by impending respiratory failure. During an acute asthma attack, patients typically hyperventilate to overcome airway resistance, which leads to a primary respiratory alkalosis (low PaCO2 and high pH). If a patient with a severe asthma exacerbation has a 'normal' or elevated PaCO2 (e.g., 44 mm Hg) and a normal pH, it is a highly concerning sign of respiratory muscle fatigue and impending respiratory arrest. The clinical picture of exhaustion, decreased respiratory rate, and 'silent chest' (diminished wheezing and air entry) further confirms that she is no longer able to maintain adequate minute ventilation. Immediate endotracheal intubation and mechanical ventilation are required to secure the airway and provide adequate gas exchange.

Step-by-Step Solution

Analyze the patient's initial presentation and clinical trajectory over the first 45 minutes.

The patient initially had severe respiratory distress (RR 32/min) but later became exhausted and lethargic, with a dropping respiratory rate (16/min) and absent wheezing ('silent chest').

Recognizing the clinical signs of respiratory muscle fatigue is the first step in identifying impending respiratory failure.

Interpret the arterial blood gas (ABG) results in the context of an acute severe asthma exacerbation.

The ABG shows a 'normal' pH (7.37) and PaCO2 (44 mm Hg), which actually represents a dangerous pseudonormalization.

A patient having a severe asthma attack should be hyperventilating, leading to a respiratory alkalosis (low PaCO2). A normal or elevated PaCO2 indicates failure to maintain adequate minute ventilation.

Determine the most appropriate next step in management based on the synthesis of clinical and laboratory findings.

Endotracheal intubation and mechanical ventilation.

Impending respiratory arrest in an exhausted asthma patient requires immediate securing of the airway to prevent death.

Key Concept

In a patient with a severe asthma exacerbation, a 'normal' or elevated PaCO2 indicates respiratory muscle fatigue and impending respiratory failure, requiring immediate endotracheal intubation.

Estimated Time:1m 30s

Question 7229Question →

A 65-year-old man presents to the emergency department reporting a 2-day history of worsening dyspnea, increased cough, and a change in his sputum from clear to yellow-green. He has a 40-pack-year smoking history and a known diagnosis of chronic obstructive pulmonary disease. His current medications include a daily tiotropium inhaler and albuterol as needed. Vital signs show a temperature of 37.8°C (100.0°F), blood pressure of 145/88 mm Hg, pulse of 105/min, and respiratory rate of 24/min. Pulse oximetry reveals an oxygen saturation of 87% on ambient air. Physical examination is notable for a prolonged expiratory phase with diffuse bilateral wheezing. Cardiac examination shows a regular rate and rhythm without murmurs, rubs, or gallops. There is no jugular venous distention, and the lower extremities are free of edema.

Which of the following interventions are appropriate for the initial management of this patient? (Select all that apply)

Select all that apply

Inhaled albuterol and ipratropium therapy

Short-course systemic corticosteroid therapy

Supplemental oxygen titrated to 88% to 92% saturation

Intravenous bolus of a loop diuretic

Empiric therapy with meropenem and vancomycin

Show answer & explanation

Answer: Inhaled albuterol and ipratropium therapy; Short-course systemic corticosteroid therapy; Supplemental oxygen titrated to 88% to 92% saturation

Answer

The appropriate initial management includes inhaled albuterol and ipratropium therapy, short-course systemic corticosteroid therapy, and supplemental oxygen titrated to 88% to 92% saturation.

The patient is experiencing an acute exacerbation of chronic obstructive pulmonary disease, defined by worsening dyspnea, increased sputum volume, and increased sputum purulence. The cornerstone of initial management includes short-acting bronchodilators to relieve bronchospasm, and systemic glucocorticoids to decrease airway inflammation and shorten recovery time. Additionally, because the patient is hypoxemic (oxygen saturation 87%), supplemental oxygen is indicated. For patients with chronic obstructive pulmonary disease, the target oxygen saturation is 88% to 92% to prevent worsening hypercapnia.

Step-by-Step Solution

Diagnose the acute condition based on the clinical presentation.

The patient is experiencing an acute exacerbation of chronic obstructive pulmonary disease.

The patient has a known history of chronic obstructive pulmonary disease and presents with the cardinal symptoms of an exacerbation: increased dyspnea, increased cough, and increased sputum purulence.

Identify the standard pharmacological interventions for an acute exacerbation.

Standard therapy includes short-acting bronchodilators, systemic corticosteroids, and targeted antibiotics.

Bronchodilators relieve bronchospasm, corticosteroids reduce airway inflammation, and antibiotics treat potential bacterial triggers.

Determine the appropriate oxygen therapy goal.

Target oxygen saturation should be 88% to 92%.

In chronic obstructive pulmonary disease, excessive oxygen can worsen hypercapnia due to altered ventilation-perfusion matching and decreased hypoxic respiratory drive.

Rule out other potential diagnoses and inappropriate treatments.

Exclude heart failure and avoid overly broad-spectrum antibiotics.

The absence of jugular venous distention and edema makes heart failure less likely, so loop diuretics are not indicated. Standard antibiotics like macrolides or cephalosporins should be used rather than unnecessarily broad-spectrum agents.

Key Concept

Acute exacerbation of chronic obstructive pulmonary disease is managed with short-acting bronchodilators, systemic glucocorticoids, antibiotics (if cardinal symptoms are present), and controlled supplemental oxygen targeting a saturation of 88-92%.

Question 7230Question →

A 58-year-old man is brought to the emergency department by his wife due to worsening confusion and lethargy over the past 24 hours. The patient has a history of alcohol-induced cirrhosis and portal hypertension. He has not had any recent fever, falls, or changes in his medications. Vital signs are within normal limits. On physical examination, he is disoriented to time and place. Scleral icterus is present. When asked to hold his arms outstretched with wrists extended, a sudden, brief downward flapping of the hands is observed. Laboratory studies show a normal leukocyte count, an elevated serum ammonia level, and normal serum electrolytes. Which of the following is the most appropriate next step in management?

Administration of intravenous haloperidol

Administration of intravenous broad-spectrum antibiotics

Administration of oral lactulose

Emergent hemodialysis

Transjugular intrahepatic portosystemic shunt placement

Show answer & explanation

Answer: Administration of oral lactulose

Answer

Administration of oral lactulose

The correct answer is the administration of oral lactulose. This patient's presentation of confusion, lethargy, and asterixis in the setting of known cirrhosis is classic for hepatic encephalopathy. Hepatic encephalopathy is driven by the accumulation of neurotoxins, primarily ammonia, which the impaired liver is unable to effectively metabolize into urea. Lactulose is a non-absorbable synthetic sugar. In the colon, it is broken down by colonic bacteria into short-chain fatty acids, which lowers the colonic pH. This acidic environment converts absorbable ammonia (NH3) into non-absorbable ammonium (NH4+), trapping it in the colon so it can be safely excreted in the stool. This mechanism effectively lowers systemic ammonia levels and rapidly improves the encephalopathy.

Step-by-Step Solution

Identify the primary clinical syndrome from the patient's symptoms and physical examination findings.

The patient has confusion, lethargy, and asterixis (flapping tremor) in the setting of cirrhosis and elevated ammonia.

These findings are classic for an acute episode of hepatic encephalopathy.

Determine the first-line pharmacologic treatment for this syndrome.

Oral lactulose should be administered.

Lactulose effectively lowers systemic ammonia levels by trapping it in the colon as ammonium for excretion.

Key Concept

Hepatic encephalopathy is a common complication of cirrhosis presenting with altered mental status and asterixis; first-line treatment is oral lactulose to safely reduce systemic ammonia levels.

Question 7231Question →

A $50$ -year-old man presents to the clinic with a $6$ -month history of progressively worsening exertional dyspnea, fatigue, and bilateral lower extremity swelling. He also reports frequent morning headaches and excessive daytime sleepiness that interferes with his work. He does not smoke and has no history of pulmonary disease. His body mass index (BMI) is $44 \text{ kg/m}^2$ .

Vital signs show a blood pressure of $148/92 \text{ mmHg}$ , a heart rate of $88/\text{min}$ , and a respiratory rate of $16/\text{min}$ . Pulse oximetry on room air is $87\%$ . Physical examination reveals an obese man with a thick neck. Cardiac auscultation demonstrates a loud pulmonic component of the second heart sound ( $P_2$ ). Lungs are clear to auscultation bilaterally. He has $2+$ pitting edema in both lower extremities.

Laboratory evaluation reveals a hematocrit of $58\%$ . An arterial blood gas on room air shows:

Parameter	Value
pH	$7.36$
$\text{PaCO}_2$	$58 \text{ mmHg}$
$\text{PaO}_2$	$55 \text{ mmHg}$
$\text{HCO}_3^-$	$32 \text{ mEq/L}$

Which of the following is the most appropriate initial long-term management for this patient's underlying condition?

Nocturnal noninvasive positive-pressure ventilation

Daily administration of oral furosemide

Continuous supplemental oxygen therapy alone

Oral azithromycin and systemic corticosteroids

Oral acetazolamide

Show answer & explanation

Answer: Nocturnal noninvasive positive-pressure ventilation

Answer

Nocturnal noninvasive positive-pressure ventilation

The correct management is nocturnal noninvasive positive-pressure ventilation (NPPV). This patient's presentation of severe obesity, excessive daytime sleepiness, cor pulmonale (loud

P_2

, lower extremity edema), polycythemia, and daytime hypercapnia (

\text{PaCO}_2 > 45 \text{ mmHg}

) is diagnostic of Obesity Hypoventilation Syndrome (OHS), also known as Pickwickian syndrome. Chronic hypoxemia and hypercapnia lead to hypoxic pulmonary vasoconstriction, resulting in pulmonary hypertension and subsequent right-sided heart failure. NPPV (often strictly continuous positive airway pressure or bilevel positive airway pressure) is the first-line therapy. It splints the upper airways open to prevent obstructive apneas and provides positive pressure to augment alveolar ventilation, effectively blowing off excess carbon dioxide and reversing the pulmonary vasoconstriction.

Step-by-Step Solution

Analyze the patient's physical symptoms and history.

The patient is obese (BMI

44 \text{ kg/m}^2

) with daytime sleepiness, morning headaches, polycythemia (hematocrit

58\%

), and signs of right-sided heart failure (loud

P_2

, edema).

These findings are the classic presentation of chronic hypoxemia and hypercapnia leading to cor pulmonale.

Interpret the arterial blood gas (ABG) results.

The ABG shows a pH of

7.36

(low-normal), an elevated

\text{PaCO}_2

58 \text{ mmHg}

, and an elevated

\text{HCO}_3^-

32 \text{ mEq/L}

This pattern represents a fully compensated chronic respiratory acidosis. The hypoxemia (

\text{PaO}_2

55 \text{ mmHg}

) and hypercapnia in an obese patient confirm Obesity Hypoventilation Syndrome (OHS).

Determine the most appropriate initial management for the diagnosed condition.

The primary therapy must address the underlying hypoventilation to correct the chronic respiratory acidosis and secondary pulmonary hypertension.

Nocturnal noninvasive positive-pressure ventilation (NPPV) provides the necessary ventilatory support to clear carbon dioxide and correct hypoxemia during sleep, breaking the cycle of pulmonary vasoconstriction.

Key Concept

Obesity Hypoventilation Syndrome (OHS) is characterized by obesity, daytime hypercapnia, and hypoxemia leading to secondary pulmonary hypertension (cor pulmonale). The first-line treatment is nocturnal noninvasive positive-pressure ventilation and weight loss.

Estimated Time:1m 30s

Question 7232Question →

Match each of the following gastrointestinal disorders with its classic characteristic endoscopic or histopathologic finding.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Crohn disease maps to transmural inflammation with noncaseating granulomas; Ulcerative colitis maps to continuous mucosal inflammation with crypt abscesses; Celiac disease maps to villous atrophy with intraepithelial lymphocytosis; Whipple disease maps to PAS-positive macrophages in the lamina propria.

Each gastrointestinal disorder has highly specific and distinct pathological features that define its diagnosis and distinguish it from other similar conditions.

Step-by-Step Solution

Analyze the histopathologic findings associated with inflammatory bowel diseases.

Identify that transmural inflammation and noncaseating granulomas are hallmarks of Crohn disease, while continuous mucosal inflammation and crypt abscesses indicate Ulcerative colitis.

Differentiating between the two main types of inflammatory bowel disease is a fundamental clinical skill.

Evaluate the classic biopsy findings for small bowel malabsorption disorders.

Correlate villous atrophy and intraepithelial lymphocytosis with Celiac disease, and link PAS-positive macrophages to Whipple disease.

These specific microscopic features are pathognomonic and essential for definitive diagnosis of these conditions.

Key Concept

Histopathologic hallmarks of classic gastrointestinal disorders.

Question 7233Question →

A 62-year-old male with a history of severe chronic obstructive pulmonary disease presents to an urgent care facility due to a two-day history of progressively worsening shortness of breath. The patient reports that his baseline chronic cough has increased in frequency, but he explicitly states his sputum remains clear and minimal in amount. He denies any fever, chills, orthopnea, or swelling in his legs. His current medications include a daily long-acting muscarinic antagonist and an albuterol inhaler, which he has been using every two hours today with minimal relief. Vital signs reveal a temperature of 37.0°C (98.6°F), blood pressure of 142/88 mm Hg, heart rate of 96/min, and respiratory rate of 22/min. Oxygen saturation is 92% on his baseline 2 L/min nasal cannula. Physical examination demonstrates a barrel-shaped chest, distant heart sounds, and a prolonged expiratory phase with scattered end-expiratory wheezes. Jugular venous pressure is normal, and there is no peripheral edema. Which of the following is the most appropriate next step in management?

Prescribe oral prednisone

Prescribe oral levofloxacin

Administer intravenous furosemide

Obtain an arterial blood gas analysis to calculate metabolic compensation

Order an urgent echocardiogram to assess left ventricular ejection fraction

Show answer & explanation

Answer: Prescribe oral prednisone

Answer

The most appropriate next step is to prescribe oral prednisone.

Systemic glucocorticoids, such as oral prednisone, are a cornerstone of treatment for acute exacerbations of chronic obstructive pulmonary disease. They help reduce airway inflammation, improve forced expiratory volume in one second (

FEV_1

), shorten recovery time, and decrease the risk of early relapse. In a patient presenting with increased breathlessness and cough but no signs of severe respiratory failure, oral corticosteroids are the most appropriate next step in management alongside short-acting bronchodilators.

Step-by-Step Solution

Identify the patient's acute clinical syndrome based on the presentation.

The patient is experiencing a mild-to-moderate acute exacerbation of chronic obstructive pulmonary disease (COPD), evidenced by increased dyspnea and increased cough frequency.

Recognizing the syndrome dictates the specific treatment pathway.

Assess for indications of a bacterial infection to guide antibiotic stewardship.

The patient lacks increased sputum purulence and increased sputum volume, meaning antibiotics are not indicated at this time.

Guidelines specify that antibiotics are reserved for exacerbations presenting with increased sputum purulence alongside other cardinal symptoms, or for those requiring mechanical ventilation.

Select the appropriate pharmacologic therapy for an uncomplicated exacerbation.

Systemic glucocorticoids (e.g., oral prednisone) and optimized short-acting bronchodilators are chosen.

These medications reduce airway inflammation, improve

FEV_1

, and reduce the risk of early relapse.

Key Concept

The initial management of an uncomplicated acute COPD exacerbation includes optimizing short-acting bronchodilators and administering systemic glucocorticoids, with antibiotics reserved only for patients displaying increased sputum purulence or those requiring mechanical ventilation.

Question 7234Question →

A $42$ -year-old woman is receiving continuous mechanical ventilation in the critical care unit due to severe acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis. Over the past $12$ hours, her oxygen saturation has declined to $84\%$ despite aggressive optimization of sedation and initiation of a continuous cisatracurium infusion.

Currently, she is receiving norepinephrine at $0.15$ $\mu\text{g/kg/min}$ . Vital signs show a blood pressure of $105/65$ mmHg and a heart rate of $98$ /min.

Ventilator parameters (Volume Assist-Control mode) are set as follows:
- Tidal volume: $380$ mL ( $6$ mL/kg predicted body weight)
- Respiratory rate: $28$ /min
- $\text{FiO}_2$ : $0.95$
- PEEP: $16$ cm $\text{H}_2\text{O}$

The ventilator display indicates a peak airway pressure of $48$ cm $\text{H}_2\text{O}$ and a plateau airway pressure of $38$ cm $\text{H}_2\text{O}$ .

An arterial blood gas demonstrates:
- pH: $7.21$
- $\text{pCO}_2$ : $58$ mmHg
- $\text{pO}_2$ : $52$ mmHg
- $\text{HCO}_3^-$ : $23$ mEq/L

Which of the following interventions should be implemented immediately? (Select all that apply)

Select all that apply

Decrease tidal volume to

4

mL/kg predicted body weight

Place the patient in the prone position

Administer intravenous sodium bicarbonate

Administer intravenous furosemide

Initiate empiric intravenous broad-spectrum antibiotics

Show answer & explanation

Answer: Decrease tidal volume to $4$ mL/kg predicted body weight; Place the patient in the prone position

Answer

Decrease tidal volume to 4 mL/kg predicted body weight AND Place the patient in the prone position

The most appropriate immediate steps are decreasing the tidal volume and placing the patient in the prone position. This patient is experiencing refractory hypoxemia and dangerously elevated airway pressures due to severe ARDS. Lung-protective ventilation strategies dictate that plateau pressure must be maintained at ≤

30

\text{H}_2\text{O}

to prevent ventilator-induced lung injury (barotrauma). Because her plateau pressure is

38

\text{H}_2\text{O}

, the tidal volume must be lowered to

4

5

mL/kg predicted body weight. This adjustment takes precedence even if it exacerbates respiratory acidosis (permissive hypercapnia). Additionally, her

\text{PaO}_2/\text{FiO}_2

ratio is

54.7

mmHg. For patients with severe ARDS (

\text{PaO}_2/\text{FiO}_2 < 150

mmHg) who remain hypoxemic despite optimized PEEP and neuromuscular blockade, prone positioning is strongly indicated as it recruits dependent posterior alveoli, improves ventilation-perfusion (V/Q) matching, and has a proven mortality benefit.

Step-by-Step Solution

Calculate the PaO2/FiO2 ratio to stratify ARDS severity.

PaO2/FiO2 = 52 / 0.95 = 54.7 mmHg (Severe ARDS).

This calculation determines eligibility for advanced interventions like prone positioning.

Evaluate the ventilator mechanics, specifically the plateau pressure.

The plateau pressure is elevated at 38 cm H2O.

Lung-protective ventilation protocols mandate maintaining a plateau pressure ≤ 30 cm H2O to prevent alveolar overdistension and barotrauma.

Determine the necessary ventilator adjustments.

Decrease tidal volume to 4 mL/kg PBW.

When plateau pressure exceeds 30 cm H2O on a 6 mL/kg tidal volume, the tidal volume must be decreased stepwise (down to 4 mL/kg) until the plateau pressure normalizes.

Determine the intervention for refractory hypoxemia.

Initiate prone positioning.

Prone positioning is strongly indicated for severe ARDS (PaO2/FiO2 < 150 mmHg) to recruit dependent lung regions and improve mortality.

Key Concept

Management of refractory hypoxemia and high plateau pressures in severe Acute Respiratory Distress Syndrome (ARDS)

Estimated Time:2m 0s

Question 7235Question →

A $28$ -year-old woman is brought to the emergency department after coughing up approximately $800 \text{ mL}$ of bright red blood over the past two hours. She has a history of cystic fibrosis and recurrent respiratory tract infections. On arrival, she is in severe respiratory distress, actively expectorating blood, and appears cyanotic. Vital signs are temperature $37.4^\circ\text{C}$ ( $99.3^\circ\text{F}$ ), heart rate $135/\text{min}$ , respiratory rate $34/\text{min}$ , and blood pressure $85/50 \text{ mm Hg}$ . Oxygen saturation is $82\%$ on room air. Breath sounds are diminished bilaterally with coarse rhonchi. Arrange the following interventions in the most appropriate sequential order for managing this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing life-threatening massive hemoptysis is to first secure the airway, then localize the bleeding with bronchoscopy, followed by bronchial artery embolization as first-line definitive therapy, reserving surgical resection as a last resort.

Massive hemoptysis (defined as

>600 \text{ mL}

of blood loss in 24 hours or a rate that threatens gas exchange) is a life-threatening emergency. Because the anatomic dead space of the major airways is only about

150 \text{ mL}

, blood rapidly floods the alveoli, making asphyxiation the primary mechanism of death. Therefore, securing the airway and ensuring adequate ventilation is the absolute first step. Once the patient is stabilized, bronchoscopy is performed to clear the airways and localize the source of bleeding. With the bleeding site identified, bronchial artery embolization is the preferred first-line definitive treatment due to its high success rate and significantly lower morbidity compared to surgery. Emergency surgical resection carries very high mortality and is strictly reserved for cases where embolization fails or is contraindicated.

Step-by-Step Solution

Secure the airway via endotracheal intubation.

Protects the non-bleeding lung and ensures adequate ventilation.

The leading cause of mortality in massive hemoptysis is asphyxiation from blood flooding the alveoli. Immediate airway protection takes precedence over all other interventions.

Perform bedside flexible bronchoscopy.

Clears blood clots and identifies the specific anatomical source of the hemorrhage.

Required to direct subsequent definitive therapy and can occasionally provide temporary control via balloon tamponade or cold saline lavage.

Proceed with bronchial artery embolization.

Achieves endovascular hemostasis.

This is the preferred, minimally invasive first-line definitive treatment for massive hemoptysis, offering high success rates with lower morbidity than surgery.

Perform emergency surgical resection.

Removes the bleeding lung segment or lobe.

Considered a salvage procedure due to its high perioperative mortality; utilized only when embolization is unavailable or fails to control the hemorrhage.

Key Concept

Algorithm for massive hemoptysis management: Airway stabilization (ABCs) -> Endoscopic localization -> Endovascular embolization -> Surgical salvage.

Estimated Time:1m 30s

Question 7236Question →

An emergency response team evaluates a $65$ -year-old female in the resuscitation bay for sudden-onset respiratory distress. The patient's husband states she has been experiencing progressive exertional fatigue over the past week and abruptly awoke gasping for air early this morning. Her medical history includes diet-controlled type 2 diabetes, essential hypertension, and a long-standing history of tobacco use ( $45$ pack-years). Her home medications are metformin and lisinopril, though she admits to frequent nonadherence.

Upon initial assessment, her temperature is $36.8^{\circ}\text{C}$ ( $98.2^{\circ}\text{F}$ ), blood pressure is $192/110\text{ mm Hg}$ , pulse is $118/\text{min}$ , and respiratory rate is $30/\text{min}$ . Pulse oximetry displays an oxygen saturation of $86\%$ on ambient air. The patient is diaphoretic and speaks in one-word sentences. Pulmonary auscultation reveals widespread, high-pitched expiratory wheezing; no rales are present. Heart rhythm is rapid and regular. Examination of the neck shows prominent sternocleidomastoid retractions, making venous assessment difficult.

An arterial blood gas analysis reveals a pH of $7.47$ , a $\text{PaCO}_2$ of $31\text{ mm Hg}$ , and a $\text{PaO}_2$ of $54\text{ mm Hg}$ . A portable anteroposterior chest radiograph demonstrates thickening of the bronchial walls (peribronchial cuffing), prominent interlobular septa, and loss of distinct margins of the hilar vessels. Both hemidiaphragms possess a normal, domed contour.

Which of the following is the most appropriate initial intervention for this patient's acute respiratory failure?

Noninvasive positive-pressure ventilation and intravenous nitroglycerin

Administration of nebulized albuterol and intravenous methylprednisolone

Intravenous piperacillin-tazobactam and a rapid isotonic saline bolus

Intravenous infusion of sodium bicarbonate

Transfer to radiology for a computed tomography pulmonary angiogram

Show answer & explanation

Answer: Noninvasive positive-pressure ventilation and intravenous nitroglycerin

Answer

Noninvasive positive-pressure ventilation and intravenous nitroglycerin

This patient's presentation is classic for sympathetic-crashing acute pulmonary edema (SCAPE), a severe form of acute decompensated heart failure driven by a hypertensive emergency. The rapid elevation in afterload leads to sudden left ventricular failure and flash pulmonary edema. While her smoking history and wheezing may initially suggest a COPD exacerbation, the objective data point firmly to a cardiogenic etiology. Patients with severe COPD exacerbations typically exhibit hyperinflation (flattened diaphragms) on radiography and often present with respiratory acidosis due to air trapping and fatigue. In contrast, this patient has normal diaphragmatic contours, radiographic signs of interstitial edema (peribronchial cuffing, indistinct hilar margins), and respiratory alkalosis driven by hypoxia-induced tachypnea. The wheezing, often termed 'cardiac asthma,' occurs because interstitial edema fluid compresses the small airways. The most appropriate initial management for this critical condition is immediate afterload reduction with intravenous nitroglycerin and respiratory support with noninvasive positive-pressure ventilation (NIPPV) to reduce the work of breathing, decrease preload/afterload, and improve alveolar gas exchange.

Step-by-Step Solution

Analyze the clinical presentation and physical exam findings.

The patient has acute, severe respiratory distress, hypoxia, severe hypertension (

192/110\text{ mm Hg}

), and diffuse wheezing.

Initial categorization of the respiratory failure is necessary. The wheezing combined with a smoking history strongly suggests COPD, but the extreme hypertension points toward a cardiovascular etiology.

Evaluate the objective diagnostic data (ABG and Chest Radiograph).

The ABG shows respiratory alkalosis (pH

7.47

\text{PaCO}_2

31\text{ mm Hg}

). The chest radiograph shows peribronchial cuffing, indistinct hilar margins, and normal diaphragms.

Objective data helps differentiate between competing diagnoses. A severe COPD exacerbation typically causes CO2 retention (respiratory acidosis) and hyperinflation (flattened diaphragms). The findings here perfectly align with interstitial pulmonary edema.

Synthesize the findings to establish a diagnosis.

The patient has 'cardiac asthma' secondary to flash pulmonary edema from a hypertensive emergency.

Acute decompensated heart failure can cause interstitial fluid to accumulate around bronchioles (peribronchial cuffing), compressing them and leading to expiratory wheezing that mimics an asthma or COPD exacerbation.

Determine the most appropriate initial management step.

Initiate noninvasive positive-pressure ventilation (NIPPV) and administer intravenous nitroglycerin.

For sympathetic-crashing acute pulmonary edema (SCAPE), immediate afterload reduction (nitroglycerin) and respiratory support (NIPPV) are required to rapidly decrease left ventricular work and improve oxygenation.

Key Concept

Cardiac Asthma vs. COPD Exacerbation

Question 7237Question →

A 68-year-old man with a history of severe chronic obstructive pulmonary disease (COPD) presents to the emergency department with worsening dyspnea, increased sputum purulence, and lethargy. Arterial blood gas analysis indicates acute-on-chronic hypercapnic respiratory failure. Arrange the following respiratory support interventions in the most appropriate sequential order of clinical escalation, from initial first-line management to the most advanced long-term support.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of escalating respiratory support begins with supplemental oxygen and bronchodilators, advances to noninvasive positive pressure ventilation (NPPV), proceeds to endotracheal intubation if noninvasive measures fail, and concludes with a tracheostomy for prolonged ventilator dependence.

The correct sequence follows the standard algorithmic approach to acute respiratory failure in COPD, minimizing invasive procedures when possible and escalating care step-by-step based on the patient's physiological response and clinical needs.

Step-by-Step Solution

Identify the initial non-invasive medical management for COPD exacerbation.

Administer supplemental oxygen and bronchodilators.

This immediately addresses life-threatening hypoxemia and treats reversible airway obstruction.

Determine the next step for persistent hypercapnic respiratory failure.

Initiate noninvasive positive pressure ventilation (NPPV).

NPPV decreases mortality and the need for intubation in COPD exacerbations presenting with respiratory acidosis.

Identify the necessary intervention for NPPV failure or worsening clinical status.

Perform endotracheal intubation and mechanical ventilation.

Provides a definitive airway and full ventilatory support when noninvasive measures are insufficient or contraindicated due to declining mental status.

Determine the long-term airway management strategy if weaning fails.

Perform a percutaneous dilatational tracheostomy.

This is a delayed intervention reserved for patients requiring prolonged mechanical ventilation, facilitating comfort and eventual weaning.

Key Concept

Sequential escalation of respiratory support in acute exacerbations of chronic obstructive pulmonary disease (COPD)

Estimated Time:1m 0s

Question 7238Question →

A $26$ -year-old man is evaluated in the emergency department for severe shortness of breath. He has a history of poorly controlled persistent asthma. Over the past two days, he has been using his albuterol inhaler every hour with minimal relief. On initial presentation, he was in severe respiratory distress with a respiratory rate of $34/\text{min}$ , prominent accessory muscle use, and minimal air entry bilaterally. He was treated aggressively with supplemental oxygen, intravenous methylprednisolone, intravenous magnesium sulfate, and continuous nebulized albuterol.

Two hours later, the patient reports feeling significantly better and is breathing more comfortably. His temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $122/76\text{ mm Hg}$ , pulse is $112/\text{min}$ , and respiratory rate is $20/\text{min}$ . Pulse oximetry is $96\%$ on a $40\%$ Venturi mask. Physical examination shows no accessory muscle use, no jugular venous distention, and pulmonary auscultation reveals good bilateral air entry with mild end-expiratory wheezing.

Arterial blood gas and serum chemistry results are as follows:

Parameter	Value
pH	$7.30$
PaCO $_2$	$33\text{ mm Hg}$
PaO $_2$	$88\text{ mm Hg}$
Sodium	$139\text{ mEq/L}$
Potassium	$3.6\text{ mEq/L}$
Chloride	$100\text{ mEq/L}$
Bicarbonate	$16\text{ mEq/L}$
Lactic acid	$5.1\text{ mmol/L}$

Which of the following is the most appropriate next step in management?

Transition to intermittent albuterol nebulization and observe

Perform endotracheal intubation and mechanical ventilation

Administer intravenous sodium bicarbonate

Administer intravenous furosemide

Administer intravenous piperacillin-tazobactam

Show answer & explanation

Answer: Transition to intermittent albuterol nebulization and observe

Answer

The correct management is to transition to intermittent albuterol nebulization and observe.

The correct action is to transition to intermittent albuterol nebulization and observe. This patient presented with a severe asthma exacerbation and was treated with continuous nebulized albuterol. He now exhibits a high anion gap metabolic acidosis (

AG = 139 - (100 + 16) = 23

) driven by an elevated lactate (

5.1\text{ mmol/L}

). Albuterol is a beta-2 adrenergic agonist that can cause a Type B lactic acidosis (without tissue hypoxia) by stimulating skeletal muscle glycolysis and lipolysis faster than pyruvate can be utilized, leading to lactate accumulation. This is a common, benign phenomenon that resolves as the beta-agonist is spaced out. Importantly, his arterial blood gas must be interpreted in context. Using Winter's formula (

PaCO_2 = 1.5 \times 16 + 8 = 32 \pm 2

), we see that his

PaCO_2

33\text{ mm Hg}

is perfect respiratory compensation for his metabolic acidosis. Because he is clinically improving (decreased respiratory rate, better air movement, subjective relief), this

PaCO_2

indicates appropriate physiological compensation, not impending respiratory failure.

Step-by-Step Solution

Analyze the patient's basic metabolic panel to determine the primary acid-base disorder.

The anion gap is calculated as Sodium - (Chloride + Bicarbonate) = 139 - (100 + 16) = 23. This indicates a primary high anion gap metabolic acidosis.

Identifying the primary disorder is the first step in acid-base interpretation, directing the search for the underlying etiology (in this case, lactic acidosis from albuterol).

Apply Winter's formula to determine if the measured PaCO2 represents appropriate respiratory compensation or a secondary respiratory disorder.

Expected PaCO2 = (1.5 * HCO3) + 8 = (1.5 * 16) + 8 = 24 + 8 = 32 \pm 2 mm Hg. The patient's actual PaCO2 is 33 mm Hg.

Because the actual PaCO2 exactly matches the expected PaCO2, the patient has a pure high anion gap metabolic acidosis with appropriate respiratory compensation. There is no concurrent respiratory acidosis.

Correlate the objective acid-base findings with the clinical trajectory.

The patient's work of breathing has decreased, air entry has improved, and he feels better. The lactic acidosis is Type B, driven by systemic beta-2 agonist (albuterol) therapy which increases glycolysis and lactate production.

Understanding the clinical context prevents the misinterpretation of the 'normalizing' PaCO2 (33 mm Hg) as a sign of respiratory muscle fatigue.

Determine the therapeutic intervention based on the clinical resolution.

Because the asthma exacerbation is resolving and the lactic acidosis is an expected, benign side effect of the treatment, the correct step is to observe and begin spacing out the albuterol.

Unnecessary interventions like intubation or bicarbonate administration would be harmful in a patient who is actively improving.

Key Concept

Patients receiving high-dose beta-2 agonists for severe asthma frequently develop a benign, self-limiting Type B lactic acidosis; expected respiratory compensation (lowered PaCO2) should be calculated using Winter's formula to distinguish this from impending respiratory failure.

Alternative Method

Whenever evaluating a blood gas in an asthmatic patient, correlate the PaCO2 directly with the clinical work of breathing. If the patient is speaking in full sentences, has a respiratory rate of 20, and air entry is good, a PaCO2 of 35 is highly unlikely to represent muscle fatigue and is almost certainly compensation for a metabolic process.

Estimated Time:2m 30s

Question 7239Question →

A 62-year-old woman is brought to the emergency department due to sudden onset of severe shortness of breath and lightheadedness. She underwent a right total hip arthroplasty 10 days ago. Her temperature is 37.1°C (98.8°F), blood pressure is 76/48 mm Hg, pulse is 128/min, and respirations are 28/min. Pulse oximetry shows 87% on room air. Physical examination reveals a patient in severe respiratory distress. The jugular venous pressure is estimated at 13 cm H2O. Auscultation of the lungs reveals clear breath sounds bilaterally. Cardiac auscultation reveals a regular tachycardia and a prominent P2, but no murmurs or gallops. The right lower extremity is mildly swollen and tender to palpation compared to the left. Which of the following is the most appropriate next step in the management of this patient?

Bedside transthoracic echocardiography

Computed tomography pulmonary angiography

Intravenous administration of furosemide

Intravenous administration of broad-spectrum antibiotics

Measurement of serum D-dimer concentration

Show answer & explanation

Answer: Bedside transthoracic echocardiography

Answer

Bedside transthoracic echocardiography

The correct answer is bedside transthoracic echocardiography. This patient's sudden-onset severe dyspnea, clear lungs, elevated jugular venous pressure, and hypotension 10 days after major orthopedic surgery are highly suggestive of a massive pulmonary embolism (PE) causing right ventricular failure and obstructive shock. In a hemodynamically unstable patient with suspected massive PE, transport to the radiology department for a computed tomography (CT) pulmonary angiography is highly unsafe. Instead, bedside transthoracic echocardiography is the most appropriate next step. It can rapidly identify signs of acute right ventricular dysfunction (e.g., right ventricular dilation, tricuspid regurgitation, McConnell's sign) to support the diagnosis of massive PE and justify the administration of immediate thrombolytic therapy if no contraindications exist.

Step-by-Step Solution

Evaluate the patient's hemodynamic status and synthesize the clinical presentation.

The patient has obstructive shock (hypotension, tachycardia) and acute right heart strain (elevated JVP, prominent P2) 10 days after major orthopedic surgery, which strongly indicates a massive pulmonary embolism.

Identifying hemodynamic instability is the critical branch point in the pulmonary embolism treatment algorithm.

Determine the safest initial diagnostic modality for a hemodynamically unstable patient.

Select bedside transthoracic echocardiography.

Transporting unstable patients for definitive imaging like CT pulmonary angiography is strictly contraindicated due to the high risk of fatal decompensation away from resuscitation equipment.

Key Concept

In hemodynamically unstable patients with a high clinical suspicion for massive pulmonary embolism, bedside transthoracic echocardiography is the most appropriate initial diagnostic step to identify right ventricular dysfunction, as transporting the patient for a CT scan is unsafe.

Estimated Time:1m 15s

Question 7240Question →

Paramedics transport a 70-year-old male with a known history of severe chronic obstructive pulmonary disease to the acute care bay. His wife activated emergency services after noting a two-day history of progressively darkening sputum and profoundly labored breathing. Triage assessment reveals an oxygen saturation of 85% on ambient air, though the patient remains fully awake, interactive, and able to answer questions in short phrases. Assume his clinical trajectory over the subsequent week encompasses initial stabilization, progressive decompensation requiring maximal life support, and eventual recovery. Arrange the following clinical interventions in the appropriate chronological sequence of standard care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Initial medical stabilization (Oxygen/Bronchodilators), Diagnostic confirmation of respiratory failure (ABG), Non-invasive support (NIPPV), Escalation to invasive support (Intubation) due to failure, and finally Liberation (SBT).

The management of acute exacerbations of COPD with respiratory failure follows a highly structured escalation algorithm. The immediate priority is addressing life-threatening hypoxemia with controlled oxygen and stabilizing medications. Once initial interventions are active, an ABG is necessary to quantify gas exchange. The ABG results dictate the next step: a

pH

< 7.35 with hypercapnia in an alert patient mandates NIPPV. If NIPPV fails, characterized by worsening acidemia or altered mental status, the patient must be escalated to invasive mechanical ventilation. Finally, after the underlying disease process resolves, standard critical care protocols require an SBT before liberation from the ventilator.

Step-by-Step Solution

Administer controlled oxygen and bronchodilators.

Initial correction of severe hypoxemia (

SpO_2

85%) and relief of bronchospasm.

Hypoxia is the most immediate life-threat. In COPD, oxygen is titrated strictly to 88-92% to avoid exacerbating hypercapnia via the Haldane effect and loss of hypoxic vasoconstriction.

Obtain an arterial blood gas.

Identification of the patient's baseline acid-base status.

An ABG is required to formally diagnose acute-on-chronic hypercapnic respiratory failure and evaluate if the patient meets criteria for noninvasive ventilation (

pH

< 7.35,

PaCO_2

> 45 mmHg).

Initiate NIPPV.

Provision of ventilatory support to reduce the work of breathing.

For an alert patient with a

pH

of 7.28, NIPPV reduces mortality, decreases intubation rates, and shortens hospital stays.

Perform endotracheal intubation.

Securing the airway and taking full control of ventilation.

The development of lethargy (encephalopathy from worsening hypercapnia) is a strict contraindication to continuing NIPPV due to high aspiration risk and failure to protect the airway.

Conduct a Spontaneous Breathing Trial (SBT).

Assessment of the patient's ability to breathe independently.

Once the primary trigger (e.g., infection, bronchospasm) is treated, an SBT must be performed to ensure the patient has adequate respiratory muscle strength to be successfully extubated.

Key Concept

The algorithmic escalation of respiratory support in acute exacerbations of COPD.

Estimated Time:1m 30s

PreviousPage 362 / 414Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution